Search Results
Researchers participating in the Blueprint Neurotherapeutics Network for Biologics receive grant funding (a UG3/UH3 award or U44 award if a small business) and no-cost access to biotherapeutic development consultants and contract research organizations (CROs).
Research Grants (UG3/UH3 or U44)
All projects that enter BPN-Biologics begin with a UG3 phase (or U44 Phase I) of up to two years, which should be used to complete all lead optimization activities (for Discovery-stage projects) or any additional preparatory activities needed to…
Institute specific interests are briefly described below, whereas more detailed descriptions can be found within the BPN-Biologics notices of funding opportunities. Interested applicants are highly encouraged to contact NIH…
When are applications due?
Upcoming application due dates for PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3…
Funding for Assay Development and Screening
- PAR-21-124: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed).
Friday, January 15, 2021
Image
Many people may not think it takes resilience to become a scientist, but Penn State graduate student Berenice Anaya says otherwise.
Read full article in PennState News
Friday, January 22, 2021
Image
New program aims to raise interest and opportunities in neuroscience research for individuals who are typically underrepresented in the field.
Read full article in Nevada Today
Image
Innovators developing groundbreaking medical device technologies face a number of challenges along the translational path from bench to bedside. The Blueprint MedTech program is an NIH incubator that aims to address such challenges and support the innovators by accelerating the development of cutting-edge medical devices to diagnose and/or treat disorders of the nervous system. The mission of the program is to catalyze the translation of novel technologies from early-stage development to…
… due dates for the above funding announcements: February 9, 2024; July 15, 2024; January 15, 2024 To learn more about BPN for Small Molecules: View …
… Wednesday, May 15, 2024 Image July 30, 2024 | 1:00 - 2:30 PM ET Register We invite you to take part …